Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Wellbutrin SR

Wellbutrin SR
In stock
150mg
from 43,57 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
52,29 £43,57 £
1,45 £ per tablet

In brief

  • Wellbutrin SR is a sustained-release tablet holding 150 mg of bupropion hydrochloride, available here as an imported generic.
  • Six quantities are listed, from 30 up to 360 tablets, all of them at the 150 mg strength.
  • Bupropion on its own is licensed in Britain only as Zyban, a POM to help smokers quit; the Wellbutrin name is not used in the UK.

Wellbutrin SR: bupropion released slowly

Wellbutrin SR is an imported generic in which bupropion hydrochloride is released gradually from a 150 mg tablet over several hours. Bupropion acts chiefly on the brain messengers noradrenaline and dopamine, which sets it apart from SSRI antidepressants such as citalopram or fluoxetine. No medicine sold in Britain carries the Wellbutrin name, so the guidance below is taken from the UK SmPC for Zyban, which contains the same active substance at the same strength.

The UK licensing picture for bupropion

Zyban 150 mg prolonged-release tablets are the only UK product with bupropion as the sole ingredient. They are prescription-only (POM) and licensed to help people who are dependent on nicotine stop smoking, used together with motivational support. Bupropion is also found, combined with naltrexone, in a tablet for weight management, which is a distinct medicine with rules of its own. No UK licence covers bupropion for depression. A prescriber who recommends Wellbutrin SR is therefore using it outside a UK licence and takes clinical responsibility for that choice.

One strength, six quantities

Wellbutrin SR is listed at 150 mg only, in quantities of 30, 60, 90, 120, 180 or 360 tablets. Each tablet should be swallowed intact. Crushing, chewing or halving it would undo the slow release and allow much of the dose to be absorbed at once, which is undesirable for a medicine whose risk of fits rises with the dose.

How the Zyban SmPC sets the dose

The Zyban SmPC has smokers begin treatment while they are still smoking and agree a target stop date within the first fortnight, ideally in the second week. For the first six days the dose is 150 mg once a day. From day seven it becomes 150 mg twice a day, taken at least eight hours apart, with the later dose kept away from bedtime because sleeplessness is so common. No single dose should exceed 150 mg, and 300 mg is the daily limit. The whole programme takes seven to nine weeks and is stopped at week seven if it has not helped by then. A single daily 150 mg dose is the recommended regimen for elderly patients and for anyone with mild to moderate hepatic or renal impairment. It is not recommended for anyone under 18, and it may be taken with or without food.

Situations that rule bupropion out

The main worry is seizures. According to the SmPC, bupropion must not be used by anyone with a current or past seizure disorder, a tumour of the central nervous system, or who is in the middle of abruptly stopping alcohol or a benzodiazepine. It is also contraindicated with present or previous bulimia or anorexia nervosa, severe hepatic cirrhosis, a history of bipolar illness, or alongside any other medicine containing bupropion. A gap of at least 14 days is required after an irreversible MAOI, and 24 hours after a reversible one. Anyone who has a fit during treatment should stop and never take bupropion again.

Interacting drugs and blood pressure checks

Bupropion inhibits CYP2D6, a liver enzyme that breaks down metoprolol, flecainide, propafenone and several antidepressants and antipsychotics, so their levels may climb. It should not be combined with tamoxifen, whose effect may be weakened. When another medicine already lowers the seizure threshold, the daily dose should go no higher than 150 mg. Clopidogrel and ticlopidine push bupropion exposure up, while carbamazepine, phenytoin, ritonavir and efavirenz bring it down. A further antidepressant of the SSRI or SNRI type adds the danger of serotonin syndrome. Raised blood pressure, sometimes severe, has been reported, so it is measured at the start and during treatment, and weekly if nicotine patches are also used.

Side effects reported with Wellbutrin SR

Insomnia is very common, affecting over 10% of users. Other common effects are headache, tremor, dizziness, difficulty concentrating, an altered sense of taste, dry mouth, nausea, vomiting, stomach pain, constipation, anxiety, agitation, depression, rash, itching, sweating and fever. A fit, worsening mood or thoughts of self-harm while taking Wellbutrin SR need urgent medical attention. Whether Wellbutrin SR is appropriate is for the doctor or prescriber to decide.

Related products